Rasagiline is neuroprotective in an experimental model of brain ischemia in the rat

Journal of Neural Transmission

Volumn 114, Issue 5, 2007, Pages 595-605

  Speiser, Z ^a   Mayk, A ^b   Litinetsky, L ^b   Fine, T ^b   Nyska, A ^a   Blaugrund, E ^b   Cohen, S ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEVA PHARMACEUTICALS   (Israel)

Author keywords

Cognition; Histopathological outcome; Infarct volume; Middle cerebral artery occlusion; Neurological severity score

Indexed keywords

PLACEBO; RASAGILINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOLUS INJECTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; COGNITION; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; MALE; MAZE TEST; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM; STROKE; TREATMENT OUTCOME;

ANIMALS; BRAIN INFARCTION; BRAIN ISCHEMIA; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; INDANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MAZE LEARNING; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 34247511535     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-006-0612-5     Document Type: Article

References (53)

1. ZA Abassi O Binah MB Youdim 2004 Cardiovascular activity of rasagiline, a selective and potent inhibitor of mitochondrial monoamine oxidase B: comparison with selegiline Br J Pharmacol 143 371 378
2. S Abu-Raya E Blaugrund V Trembovler E Shilderman-Bloch E Shohami P Lazarovici 1999 Rasagiline, a monoamine oxidase-B inhibitor, protects NGF-differentiated PC12 cells against oxygen-glucose deprivation J Neurosci Res 58 456 463
3. N Ahmed P Näsman NG Wahlgren 2000 Effect of intravenous nimodipine on blood pressure and outcome after acute stroke Stroke 31 1250 1255
4. Y Akao W Maruyama S Shimizu H Yi Y Nakagawa M Shamoto-Nagai MB Youdim Y Tsujimoto M Naoi 2002a Mitochondrial permeability transition mediates apoptosis induced by N-methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl-2 and Rasagiline, N-propargyl-1(R)-aminoindan J Neurochem 82 913 923
5. Y Akao W Maruyama H Yi M Shamoto-Nagai MB Youdim M Naoi 2002b An anti-Parkinson's disease drug, N-propargyl-1(R)-aminoindan (Rasagiline), enhances expression of anti-apoptotic bcl-2 in human dopaminergic SH-SY5Y cells Neurosci Lett 326 105 108
6. DL Alkon H Epstein A Kuzirian MC Bennell TJ Nelson 2005 Protein synthesis required for long term memory is induced by PKC activation on days before associative learning Proc Natl Acad Sci USA 102 16432 16437
7. KS Ansari PH Yu TPA Krock WG Tatton 1993 Rescue of axotomized immature rat facial motorneurons by R(-)deprenyl: stereoselectivity and independence from monoamine oxidase inhibition J Neurosci 13 4042 4053
8. GW Bielenberg TH Beck 1991 The effect of dizolcipine (MK-801), phencyclidine, and nimodipine on infarct size 48 h after middle cerebral artery occlusion in the rat Brain Res 552 338 342
9. F Blandini MT Armentero R Fancellu E Blaugrund G Nappi 2004 Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease Exp Neurol 187 455 459
10. AA Boulton BA Davis DA Durden LE Dyck AV Juorio XM Li IA Paterson PH Yu 1997 Aliphatic propargylamines: new apoptotic drugs Drug Res 42 150 156
11. YM Buys GE Trope WG Tatton 1995 (-)Deprenyl increases the survival of rat retinal ganglion cells after optic nerve growth Curr Eye Res 14 119 126
12. P Coyle 1975 Arterial patterns of the rat rhinencephalon and related structures Exp Neurol 49 671 690
13. S Eliash Z Speiser S Cohen 2001 Rasagiline and its (S) enantiomer increase survival and prevent stroke in salt-loaded stroke-prone spontaneously hypertensive rats J Neural Transm 108 909 923
14. S Eliash N Shteter R Eilam 2005 Neuroprotective effect of rasagiline, a monoamine oxidase-B inhibitor, on spontaneous cell degeneration in a rat model J Neural Transm 112 991 1003
15. JP Finberg T Takeshima JM Johnston JW Commissiong 1998 Increased survival of dopaminergic neurons by Rasagiline, a monoamine oxidase B inhibitor Neuroreport 9 703 737
16. DJ Gladstone SE Black AM Hakim 2002 Toward wisdom from failure. Lessons from neuroprotective stroke trials and new therapeutic directions Stroke 33 2123 2136
17. J Goggi S Theofilopoulos SS Riaz E Jauniaux GM Stern HF Bradford 2000 The neuronal survival effects of rasagiline and deprenyl on fetal human and rat ventral mesencephalic neurones in culture Neuroreport 11 3937 3941
18. W Haefely WP Burkard A Cesura A Colbi R Kettler HP Lorez JR Martin JL Moreau JG Richards R Schaffner R Scherchlicht J Sepinwall M Da Prada 1993 Pharmacology of moclobemide Clin Neuropharmacol 16 Suppl 2 S8 S18
19. W Huang Y Chen E Shohami M Weinstock 1999 Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse Eur J Pharmacol 366 127 135
20. TJ Hudzik A Borrelli P Bialobok D Widzowski S Sydserff A Howell P Gendron D Corbett J Miller GC Palmer 2000 Long-term functional end points following middle cerebral artery occlusion in the rat Pharmacol Biochem Behav 65 553 562
21. J Jolkkonen R Kauppinen L Nyman A Haapalinna J Sivenius 2000 MAO-B inhibition by a single dose of L-Deprenyl or lazabemide does no prevent neuronal damage following focal cerebral ischemia in rats Pharmacol Toxicol 87 242 245
22. S Knollema W Aukema H Hom J Korf GJ Ter-Horst 1995 L-Deprenyl reduces brain damage in rats exposed to transient hypoxia-ischemia Stroke 26 1883 1887
23. S Mandel O Weinreb T Amit MB Youdim 2005 Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives Brain Res Rev 48 379 387
24. W Maruyama Y Akao MC Carrillo K Kitani MB Youdium M Naoi 2002 Neuroprotection by propargylamines in Parkinson's disease: suppression of apoptosis and induction of prosurvival genes Neurotoxicol Teratol 24 675 682
25. W Maruyama Y Akao MBH Youdim BA Davis N Makato 2001 Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehydes-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol J Neurochem 78 727 735
26. W Maruyama T Yamamoto K Kitani MC Carrillo M Youdim M Naoi 2000a Mechanism underlying anti-apoptotic activity of a (-)deprenyl-related propargylamine, rasagiline Mech Ageing Dev 116 181 191
27. W Maruyama M Youdim M Naoi 2000b Anti-apoptotic function of N-propargylamine-1(R) and (S) aminoindan, Rasagiline and TV1022 Ann NY Acad Sci 939 320 325
28. B Mattsson JC Sorensen J Zimmer BB Johansson 1997 Neural grafting to experimental neocortical infarcts improves behavioral outcome and reduces thalamic atrophy in rats housed in enriched but not in standard environments Stroke 28 1225 1232
29. CP Montoya LJ Campbell-Hope KD Pemberton SB Dunnett 1991 'The staircase test' a measure of independent forelimb reaching and grasping abilities in rats J Neurosci Methods 36 219 228
30. C Mytilineou P Radclife E Kokotos Leonardi P Werner CW Olanow 1997 L-Deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro J Neurochem 68 33 39
31. Parkinson Study Group 2004 The Tempo study. A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease Arch Neurol 62 561 566
32. Parkinson Study Group 2005 A randomized placebo-controlled trail of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations. The Presto study Arch Neurol 62 241 248
33. G Paxinos C Watson 2005 The rat brain in stereotaxic coordinates 5 Elsevier Academic Press San Diego
34. O Rascol DJ Brooks E Melamed W Oertel W Poewe F Stocchi E Tolosa LARGO study group 2005 Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial Lancet 365 947 954
35. T Schallert IQ Whishaw 1984 Bilateral cutaneous stimulation of the somatosensory system in hemidecorticale rats Behav Neurosci 98 518 540
36. I Semkova P Wolz M Schilling J Krieglstein 1996 Rasagiline enhances NGF synthesis and protects central nervous neurons from excitotoxic and ischemic damage Eur J Pharmacol 315 19 30
37. NA Seniuk JT Henderson WG Tatton JC Roder 1994 Increased CNTF gene expression in process bearing astrocytes following injury is augmented by R(-)deprenyl J Neurosci Res 37 278 286
38. L Simon G Szilagyi Z Bori P Orbay Z Nagy 2001 (-)-D-Deprenyl attenuates apoptosis in experimental brain ischemia Eur J Pharmacol 430 235 241
39. SE Smith H Hodges P Sowinski CM Man MJ Leach JD Sinden JA Gray BS Meldrem 1997 Long-term beneficial effects of BW 619C89 on neurological deficit, cognitive deficit and brain damage after middle cerebral artery occlusion in the rat Neuroscience 77 1123 1135
40. Z Speiser O Katzir M Rehavi T Zabarski S Cohen 1998a Sparing by rasagiline (TVP-1012) of cholinergic functions and behavior in the postnatal anoxia rat Pharmacol Biochem Behav 60 387 393
41. Z Speiser R Levy S Cohen 1998b Effects of N-propargyl-1-(R) aminoindan (Rasagiline) in models of motor and cognition disorders J Neural Transm Suppl 52 287 300
42. Z Speiser A Mayk S Eliash S Cohen 1999 Studies with rasagiline, a MAO-B inhibitor, in experimental focal ischemia in the rat J Neural Transm 106 593 606
43. RP Stroemer TA Kent CE Hulsebosch 1998 Enhanced neocortical neuronal sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats Stroke 29 2381 2395
44. Stroke Therapy Academic Industry Roundtable (STAIR) 1999 Recommendation for standards regarding preclinical neuroprotective and restorative drug development Stroke 30 2752 2758
45. A Tamura DI Graham J McCulloch GM Teasdale 1981 Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion J Cereb Blood Flow Metab 1 53 60
46. WG Tatton RM Chalmers Redman WY Ju J Wadia NA Tatton 1997 Apoptosis in neurodegenerative disorders: potential for therapy modifying gene transcription J Neural Transm Suppl 49 245 268
47. WG Tatton RM Chalmers Redman N Tatton 2003 Neuroprotection by deprenyl and other propargylamines: glyceraldehydes-3-phosphate dehydrogenase rather than monoamine oxidase B J Neural Transm 110 509 515
48. WG Tatton WY Ju DP Holland C Tai M Kwan 1994 (-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis J Neurochem 63 1572 1575
49. M Yogev-Falach T Amit O Bar-Am MB Youdim 2003 The importance of propargylamine moiety in the anti-Parkinson drug rasagiline and its derivatives in MAPK-dependent amyloid precursor protein processing FASEB J 17 2325 2327
50. MB Youdim O Bar-Am M Yogev-Falach O Weinreb W Maruyama M Naoi T Amit 2005 Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability transition J Neurosci Res 79 172 179
51. PH Yu BA Davis DA Durden A Barber I Terleckyj WG Nicklas AA Boulton 1994a Neurochemical and neuroprotective effects of some aliphatic propargylamines: new selective nonamphetamine - like monoamine oxidase β inhibitors J Neurochem 62 697 704
52. PH Yu BA Davis J Fang AA Boulton 1994b Neuroprotective effects of same monoamine oxidase-B inhibitors against DSP-4 induced noradrenaline depletion in the mouse hippocampus J Neurochem 63 1820 1828
53. CZ Zhu RN Auer 1995 Graded hypotension and MCA occlusion duration: effect in transient focal ischemia J Cereb Blood Flow Metab 15 980 988